Investors

Lunas.One Company

Lunas is building a medical AI company around Stethos, personal health data, Clinic collaboration, Lab research, future insurance, and device development. This page is for investors reviewing what we offer today, where Lunas can expand, and the roadmap behind the company.

Commercial paths

Five ways investors can earn over time

These are potential earning paths, not guaranteed returns or investment advice. Each depends on execution, regulation, partnerships, and adoption.

1

Stethos 1.0 subscriptions

Medical AI Assistant

Lunas begins with Stethos 1.0, a medical AI assistant for everyday health questions, lab results, records, and genome reports. The first commercial layer is monthly subscription access for individuals and higher-capacity plans for professionals. This creates a recurring software base while the product learns which workflows users value most.

2

Future insurance line

Medical Insurance

Lunas intends to explore real medical insurance as a future business line, not only insurance-adjacent software. Structured health records, preventive insights, and responsible AI can support better member experience, care navigation, and risk understanding where regulation allows. This path requires licensing, actuarial partners, compliance discipline, and strict separation between care guidance and insurance decisions.

3

Connected personal health data

Medical Wearables and Devices

Wearables and home devices can turn Lunas from a question-answering product into a daily health context layer. Over time, Stethos can help interpret trends from approved devices, user-uploaded results, and longitudinal timelines. Device work comes later because it requires prototyping, validation, regulatory discipline, and stronger data pipelines.

4

Medicine, vaccines, labs, diagnostics, and medical AI

Biomedical Research and Development

Lab is the long-term research surface for organizing findings, literature, structured results, and model-assisted analysis. This includes opportunities across diagnostics, medical AI tooling, laboratory workflows, drug discovery support, vaccines, and future medicine development. The near-term goal is to build trustworthy data infrastructure before attempting deeper biomedical automation.

5

Partner workflows

Medical Laboratories and Clinics

Clinics and laboratories can use Lunas to make results easier to review, explain, organize, and share with the right people. Partner workflows may include file-aware summaries, consultation logs, patient timelines, and controlled collaboration with professionals. This path grows only with strong privacy, auditability, and clear human review.

Roadmap

What we are building

1

Phase 1

Stethos 1.0

Launch the medical AI assistant for everyday questions, lab-result understanding, records, Clinic sharing, and Lab workflows.

2

Phase 2

Medicine R&D foundation

Establish research and development systems for medical knowledge, diagnostics, medicine, vaccines, and model-assisted laboratory work.

3

Phase 3

Stethos 2.0

Improve from consented, human-reviewed, de-identified training signals with better clinical reasoning and structured analysis.

4

Phase 4

Laboratory and clinic partnerships

Partner with medical laboratories, hospitals, and clinics for controlled workflows around records, results, consultations, and collaboration.

5

Phase 5

Stethos 3.0

Move toward owned model infrastructure and deeper personalized health reasoning across records, labs, genomics, and longitudinal context.

6

Phase 6

Wearables and device prototyping

Build the first Lunas warehouse for prototyping, development, and validation of medical wearables and connected health devices.

7

Phase 7

Rural offline partnerships

Expand rural partnerships for offline applications where connectivity is weak and timely medical context matters most.